Phosphoproteomic signatures for early detection and stratification of AML

Scott Davis

Exposures from Chernobyl

Leukaemia

Pediatric oncology or childhood cancer Radiation Oncology

Carl E Allen

Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying Biomarkers for Early Detection and Risk Assessment

Leukaemia

Lynn Goldin

Autoimmune Diseases and Risk for Lymphoma and Other Cancers

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Mitch Mcvey

Mechanisms and consequences of inaccurate DNA double-strand break repair

Leukaemia

Pathology

Peter C Adamson

COG NCTN Network Group Operations Center

Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Pediatric oncology or childhood cancer

Peter Aplan

Pre-clinical Studies of Therapy for Myelodysplastic Syndrome

Leukaemia

Hematology and hematologic malignancies

Aaron David Schimmer

Targeting mitochondrial translation as a novel therapeutic strategy for AML

Leukaemia

Derek L Stirewalt

Discovery and Optimization of AML Prognostic Biomarkers

Leukaemia

Pediatric oncology or childhood cancer